HCV

I will soon be writing about the possibility of the first-ever direct-acting antiviral drug (DAAD) for respiratory syncytial virus (RSV), courtesy of Enanta Pharmaceuticals, a Massachusetts biotech company spe

For patients awaiting an organ donor the odds are not in their favor. 120,000 patients with need, about 10,300 donors with a gift this last year.